Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lenalidomide and Paclitaxel in Advanced Solid Tumors

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2011 by Southern Europe New Drug Organization.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Southern Europe New Drug Organization
ClinicalTrials.gov Identifier:
NCT01155505
First received: June 30, 2010
Last updated: September 12, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2012
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)